373 related articles for article (PubMed ID: 11068557)
21. Transient myeloproliferative disorder and acute myeloid leukemia in Down syndrome. An immunophenotypic analysis.
Karandikar NJ; Aquino DB; McKenna RW; Kroft SH
Am J Clin Pathol; 2001 Aug; 116(2):204-10. PubMed ID: 11488066
[TBL] [Abstract][Full Text] [Related]
22. Myeloid leukemia cutis: a histologic and immunohistochemical review.
Cibull TL; Thomas AB; O'Malley DP; Billings SD
J Cutan Pathol; 2008 Feb; 35(2):180-5. PubMed ID: 18190442
[TBL] [Abstract][Full Text] [Related]
23. Diagnostic criteria for minimally differentiated acute myeloid leukemia (AML-M0). Evaluation and a proposal.
Kaleem Z; White G
Am J Clin Pathol; 2001 Jun; 115(6):876-84. PubMed ID: 11392885
[TBL] [Abstract][Full Text] [Related]
24. Bone marrow trephine findings in acute myeloid leukaemia with multilineage dysplasia.
Ngo N; Lampert IA; Naresh KN
Br J Haematol; 2008 Feb; 140(3):279-86. PubMed ID: 17973948
[TBL] [Abstract][Full Text] [Related]
25. Immunophenotypic analysis of myelodysplastic syndromes.
Del Cañizo MC; Fernández ME; López A; Vidriales B; Villarón E; Arroyo JL; Ortuño F; Orfao A; San Miguel JF
Haematologica; 2003 Apr; 88(4):402-7. PubMed ID: 12681967
[TBL] [Abstract][Full Text] [Related]
26. Immunophenotype of myeloid granulocytes: a pilot study for distinguishing myelodysplastic syndrome and aplastic anemia by flow cytometry.
Huang M; Li J; Zhao G; Sui X; Zhao X; Xu H
Int J Lab Hematol; 2010 Jun; 32(3):275-81. PubMed ID: 19968721
[TBL] [Abstract][Full Text] [Related]
27. Increased immature hematopoietic progenitor cells CD34+/CD38dim in myelodysplasia.
Monreal MB; Pardo ML; Pavlovsky MA; Fernandez I; Corrado CS; Giere I; Sapia S; Pavlovsky S
Cytometry B Clin Cytom; 2006 Mar; 70(2):63-70. PubMed ID: 16470534
[TBL] [Abstract][Full Text] [Related]
28. Identification of mature and immature human thymic dendritic cells that differentially express HLA-DR and interleukin-3 receptor in vivo.
Schmitt C; Fohrer H; Beaudet S; Palmer P; Alpha MJ; Canque B; Gluckman JC; Dalloul AH
J Leukoc Biol; 2000 Dec; 68(6):836-44. PubMed ID: 11129651
[TBL] [Abstract][Full Text] [Related]
29. Immunophenotypic features of granulocytes, monocytes, and blasts in myelodysplastic syndromes.
Moon HW; Huh JW; Lee M; Hong KS; Chung WS
Korean J Lab Med; 2010 Apr; 30(2):97-104. PubMed ID: 20445324
[TBL] [Abstract][Full Text] [Related]
30. Expression of the c-fgr and hck protein-tyrosine kinases in acute myeloid leukemic blasts is associated with early commitment and differentiation events in the monocytic and granulocytic lineages.
Willman CL; Stewart CC; Longacre TL; Head DR; Habbersett R; Ziegler SF; Perlmutter RM
Blood; 1991 Feb; 77(4):726-34. PubMed ID: 1825181
[TBL] [Abstract][Full Text] [Related]
31. Paraffin section immunophenotyping of acute leukemias in bone marrow specimens.
Arber DA; Jenkins KA
Am J Clin Pathol; 1996 Oct; 106(4):462-8. PubMed ID: 8853033
[TBL] [Abstract][Full Text] [Related]
32. CD163: a specific marker of macrophages in paraffin-embedded tissue samples.
Lau SK; Chu PG; Weiss LM
Am J Clin Pathol; 2004 Nov; 122(5):794-801. PubMed ID: 15491976
[TBL] [Abstract][Full Text] [Related]
33. Myeloid lineage involvement in acute lymphoblastic leukemia: a morphology antibody chromosomes (MAC) study.
Larramendy M; el-Rifai W; Saarinen U; Alitalo R; Luomahaara S; Knuutila S
Exp Hematol; 1995 Dec; 23(14):1563-7. PubMed ID: 8542947
[TBL] [Abstract][Full Text] [Related]
34. Podocalyxin: a marker of blasts in acute leukemia.
Kelley TW; Huntsman D; McNagny KM; Roskelley CD; Hsi ED
Am J Clin Pathol; 2005 Jul; 124(1):134-42. PubMed ID: 15923169
[TBL] [Abstract][Full Text] [Related]
35. The presence of CD56/CD16 in T-cell acute lymphoblastic leukaemia correlates with the expression of cytotoxic molecules and is associated with worse response to treatment.
Dalmazzo LF; Jácomo RH; Marinato AF; Figueiredo-Pontes LL; Cunha RL; Garcia AB; Rego EM; Falcão RP
Br J Haematol; 2009 Jan; 144(2):223-9. PubMed ID: 19016721
[TBL] [Abstract][Full Text] [Related]
36. Bcl-2 protein expression in normal human bone marrow precursors and in acute myelogenous leukemia.
Porwit-MacDonald A; Ivory K; Wilkinson S; Wheatley K; Wong L; Janossy G
Leukemia; 1995 Jul; 9(7):1191-8. PubMed ID: 7543174
[TBL] [Abstract][Full Text] [Related]
37. Immunohistochemistry can be used to subtype acute myeloid leukemia in routinely processed bone marrow biopsy specimens. Comparison with flow cytometry.
Manaloor EJ; Neiman RS; Heilman DK; Albitar M; Casey T; Vattuone T; Kotylo P; Orazi A
Am J Clin Pathol; 2000 Jun; 113(6):814-22. PubMed ID: 10874882
[TBL] [Abstract][Full Text] [Related]
38. Use of myeloperoxidase mRNA as a marker for myeloid lineage in acute leukemias.
Crisan D; David D; DiCarlo R
Arch Pathol Lab Med; 1996 Sep; 120(9):828-34. PubMed ID: 9140287
[TBL] [Abstract][Full Text] [Related]
39. Haematologic and immunophenotypic profile of acute myeloid leukemia: an experience of Tata Memorial Hospital.
Ghosh S; Shinde SC; Kumaran GS; Sapre RS; Dhond SR; Badrinath Y; Ansari R; Kumar A; Mahadik S; Chougule AB; Nair CN
Indian J Cancer; 2003; 40(2):71-6. PubMed ID: 14716122
[TBL] [Abstract][Full Text] [Related]
40. Immunophenotype in chronic myelomonocytic leukemia: is it closer to myelodysplastic syndromes or to myeloproliferative disorders?
Subirá D; Font P; Villalón L; Serrano C; Askari E; Góngora E; Castañón S; Gonzalo R; Mata R; Román A; Llamas P
Transl Res; 2008 May; 151(5):240-5. PubMed ID: 18433705
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
